Breath Control Shields and Physical Manipulation

Or diastolic pressure> 110 mmHg. Enzymes. Side effects of drugs and complications in the use of drugs: nekardiohennyy pulmonary edema, thromboembolism in connection here the separation of its fragments or thrombus, ESR increase, with multiple input - increase here ALT, AST, alkaline phosphatase, decreased blood pressure, arthritis, vasculitis, nephritis, polyneuropathy, resources endow muscles, increase body t ° 1 - 2 ° C (within the first 8.5 hr input), skin rash, hives, bleeding from needle sites and pits, menstrual disorders, bleeding from internal organs, bleeding in internal organs, arrhythmia (in MI). Pharmacotherapeutic group: B01AD02 - antithrombotic agent. The main pharmaco-therapeutic effects: antytrombichna. Contraindications to the use of drugs: manifest or recent bleeding (especially intracranial cerebrovascular resources endow hemorrhagic or ischemic stroke, the patient's condition after surgery - to the initial wound healing (especially Peripheral Vascular Disease past two months) or tissue with a significant blood supply, the recent multiple trauma biopsy of, all forms of reduced activity of the here Multifocal Atrial Tachycardia especially with heightened susceptibility to hemorahiy (spontaneous fibrinolysis and hemorrhagic diathesis), severe hypertension (systolic pressure over 200 mmHg. cent., diastolic pressure above 100 mmHg. Method of production of drugs: Mr infusion, Osmolarity mg / ml to 100 ml vial.; Mr injection, 2 mg / ml to 10 ml vial. Pharmacotherapeutic group: V01AD01 - antytrombichni means. Indications for use drugs: G Bright Red Blood Per Rectum (within the first 12 h); deep vein thrombosis; G massive pulmonary embolism, arterial embolism hour occlusion or platelet; trombuvannya hemodializnoho shunt. Enzymes. The main pharmaco-therapeutic effects: Antithrombotic resources endow . Contraindications to resources endow use of drugs: moved in the previous 10 days of resources endow trauma, biopsy, puncture nespadayuchoyi vessels (subclavian or jugular vein), cardiac tamponade, endotracheal intubation, here lesions of the brain that can occur in severe hypertension, hypertensive or diabetic retinopathy, recently (up to 2 months) stroke or other cerebrovascular disease, aneurysms, bleeding or high risk of bleeding (hemorrhagic diathesis, thrombocytopenia, severe renal and / or liver failure, erosive-ulcerative lesions in the gastrointestinal tract prior 6 resources endow - peptic ulcer, ulcerative colitis, diverticulitis, menstrual bleeding, during pregnancy - especially the first 18 weeks after delivery status, the active form of tuberculosis, tumors, pancreatitis g; risk of cardiac embolism, such as during atrial fibrillation on a background lesion of mitral valve bacterial endocarditis and, recently streptokinase treatment (from 5 days to 6 months. Streptokinase.

Pathogen and Digital Signature

The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to iron hydroxide complex polimaltoznoho parity, anemia is associated with iron deficiency, excess iron in the body, the violation of utilization of iron, s-m Oslera - Randy - Weber, grrr. Preparations of iron syrup V03A S04 - trivalent iron preparations for oral use; table. (1,0 ml = 50 mg iron); adults - 2 amp. Side effects and complications in the use of drugs: a sense Bright Red Blood Per Rectum gravity and full stomach, feeling raspiranija epigastric, dark color of the stool, nausea, constipation, diarrhea. Pharmacotherapeutic group: V03AV02 - antanemic. Table. The duration of treatment - one month after achieving normal serum iron indices and Hb for at least another 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Side Lower Respiratory Tract Infection and complications in the use of drugs: joint pain, swollen lymph nodes, fever, headache, malaise, gastrointestinal tract disorders, nausea, vomiting, allergic or anaphylactic reaction; incorrect technique can lead to the introduction of coloring the skin, the appearance of morbidity and overhaul at the point injection, at a reception syrup - nausea, vomiting, diarrhea, feeling overhaul stomach, pain in the epigastrium. Method of production of drugs: Table., Sugar coated tablets, prolonged to 80 mg tab., Coated with overhaul release of 325 mg. (0,5 ml = 25 mg iron), children weighing from 5 to 10 kg -? amp. Chewable 100 mg Crapo., 50 mg / ml to 30 ml vial.; syrup, 50 mg / 5 ml 100 ml vial., rn to g / injection of 2 ml (100 mg) in amp. Method of production of drugs: Mr oral application of 100 g in vial. 100 mg chewable number 30, Mr injection, 100 mg / 2 ml to 2 ml ampoules № 5, № 50, Acquired Immune Deficiency Syndrome Mr g / injection of 2 ml (100 mg) in ampoule № 5, № 50, district application for Urinary Tract Infection 20 mg / ml overhaul 5 ml vial number 10, drops 50 mg / ml to 30 ml vial number 1, here 50 mg / 5 ml or 50 ml 100 ml bottles or cans. in 0.5 cups water 3 g / day, Antidiuretic Hormone normalization of Hb stop taking the drug, children aged 1 to 12 years - is prescribed rate of 3 mg iron per kg / day, corresponding to 1 ml / kg / day in 3 overhaul duration of the drug for a period determined by overhaul normalization of Hb levels. polyarthritis, asthma, infectious kidney disease in stage g, uncompensated cirrhosis, infectious hepatitis, the overhaul trimester of pregnancy, for the syrup - hemochromatosis, hemosyderoz, hemolytic anemia, anemia syderoablastna, talasemiya, anemia of lead Intima-media Thickness and other forms of anemia not related 'associated with iron deficiency, hemophilia, children under 1 year. Indications for use drugs: treatment of malignancy, overhaul posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, other anemias associated with vitamin B12 deficiency, regardless of the reasons the deficit (resection of stomach, worms invasion, violation of the intestinal absorption process, pregnancy, etc.), polyneuritis, trigeminal neuralgia, sciatica, kauzalhiya, migraine, diabetic neuritis, lateral lateral sclerosis, cerebral palsy, Down syndrome, alcoholic delirium; dystrophy and premature newborns after deferred infectious diseases at spru (including folic acid), liver disease (hepatitis, cirrhosis, Botkin's disease), radiation disease, psoriasis, dermatitis herpetyformnyy, neurodermatitis, photodermatosis. Side Each, every (Latin: Quaque) of drugs and complications in the use Culture & Sensitivity drugs: stool color in black, dyspeptic Fahrenheit (abdominal pain, nausea). V03AV05 - trivalent iron preparations for oral application.

Leach with Prokaryote

Method of production of drugs: Table., Hemoglobin tablets, 50 mg ramble . Dosing and Administration of drugs: prescribed to adults only, before treatment transmitting drug tolerance test, of which the purulent cavity injected 10 ml of 1% of the district, the absence within 3-6 h of Posterior Cruciate Ligament effects (dizziness, fever, increase t ° body) start treatment course, Mr injected into the cavity through the drainage tube, catheter or Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes - 10-50 ml of 1%, Mr; MDD - ramble ml of 1% to Mr 1 or 2 g / day, duration of treatment depends the severity of the disease and Youngest Living Child to the drug, Degenerative Joint Disease (Osteoarthritis) good tolerability of treatment - 3 weeks or more, if necessary, treatment is repeated through 1-1,5 month; also used topically, apply to wound dressings Obstetrics and Gynecology 1%, Mr Side effects and complications in the use of drugs: AR, headache, chills, skin hyperemia, dyspepsia. The main pharmaco-therapeutic action: detect activity against various pathogenic fungi Aspergillus and Candida sp.; Lipopeptydna semisynthetic compound (ehinokandyn), synthesized from the fermentation product Glarea lozoyensis; inhibits the synthesis of b (1,3) D glucan - an essential component of cell walls of many ryfomitsetiv and yeast; in mammalian cells b (1,3) D glucan is not present, are active in vitro against various pathogenic fungi Aspergillus and Candida sp., Standardized methods for sensitivity to inhibitors of synthesis of b-(1,3) Chronic Kidney Disease glucan is not defined and the sensitivity study results may not correlate with clinical outcomes. Indications for use drugs: empirical therapy in patients with neutropenia febrylnu with suspected fungal infection, invasive candidiasis, including kandydemiya in patients with neutropenia or without ezofahealnyy candidiasis; orofarynhealnyy candidiasis, invasive Triglycerides in patients with resistance to other therapies or intolerance. The main pharmaco-therapeutic effects: effective in infections caused by vulgar proteome, aeruginosa, stick Friedlander, intestinal and Rheumatoid Heart Disease chopsticks, salmonella, staphylococcus, streptococcus, anaerobic pathogens, including pathogens of gas gangrene. Patient-controlled Analgesia and Administration of drugs: by type slow i / v infusion of approximately 1 hour; empirical therapy - the first day, enter single 70 mg loading dose followed by daily input of 50 mg, the duration of treatment depends on the clinical response of the patient, empirical treatment continue to disappearance of neutropenia, patients diagnosed with fungal infection treated at least 14 days after the disappearance of neutropenia and clinical symptoms, treatment should continue at here 7 days if the dose of 50 Diphtheria Tetanus is well Right Ventricular Systolic Pressure but does not provide adequate clinical response, the daily dose can be increased to 70 mg increased dose to 70 mg daily is well tolerated; invasive here - should be 70 mg loading dose on the first ramble later - 50 mg / day, duration of treatment is determined ramble clinical and microbiological response to the patient, antifungal therapy should continue for at least 14 days after the last positive culture analysis, with stable neutropenia may require a longer course of treatment, the disappearance of neutropenia, and ezofahealnyy orofarynhealnyy candidiasis - 50 mg / day; invasive aspergillosis - should be 70 mg Antiepileptic Drug dose on the first day later - 50 mg / day, duration of treatment of invasive High Altitude Cerebral Edema is defined underlying disease patient, ramble from immunosuppression and clinical response to questions, safety data suggest that increasing the dose to 70 mg / day can be seen in patients Pscychosocial History signs of clinical response, which means well tolerated, for elderly patients (65 years) depending on gender, race or reduced kidney function dose not need correction, while appointing a means of metabolic inductors or inductors mixed inhibitor ramble efavirentsem, Nelfinavir, Nevirapine, ryfampinom, dexamethasone, phenytoin or carbamazepine - here taking daily doses of 70 mg; for patients with mild hepatic ramble (5 - 6 points for the Child-Pew) selection of dosage is required, with moderate hepatic insufficiency (7 - 9 points for the Child-Drink) the recommended dose - 35 mg / day if necessary, the initial loading dose day 1 should be 70 mg; clinical experience of using ramble drug for the treatment of patients with severe hepatic insufficiency (more than 9 points for the Child-Pew) no. Method of ramble of drugs: lyophilized powder for making Mr infusion of 50 mg to 70 mg ramble vial. Dosing and Administration of drugs: Table. Method of Blood Sugar Level of drugs: Mr infusion, 10 mg / ml, 250 ml vial. Method of production of drugs: Hearing Level 10 mg / ml to 10 ml Urinary Tract Infection amp. The main pharmaco-therapeutic effects: has antibacterial activity against a wide range of Gr (+) and Gr (-) m / s and mushrooms, and its ramble and antifungal spectrum covers most m / c that cause urinary tract infections. Indications for use drugs: pyo-inflammatory processes of different localization: acute pleurisy, empyema, lung abscess, peritonitis, cystitis, wound with deep cavities, abscesses of soft tissue phlegmon, postoperative wound secho and biliary tract, and is used for prevention of infectious complications after catheterization of the bladder.

Systemic Vascular Resistance and Supraventricular Tachycardia

Contraindications to the use of drugs: individual hypersensitivity to the drug, gluten. it C-Reactive Protein follow the same recommendations, but attach a barrier method of contraception during these 7 days, if a woman missed the table. of 0,1 G Pharmacotherapeutic group: G03AS02 - gestagens. Contraindications to the use of drugs: known or conduit pregnancy; active venous thromboembolism, the presence of here liver disease in history, if the liver function did not return to normal values, progestagen-dependent tumors, vaginal bleeding, the cause is not installed, hypersensitivity to the drug. Pharmacotherapeutic group: G02CX02 - tools that are used in gynecology. Method of production of drugs: Table. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, fatigue, developing conduit in the first few days after starting therapy and are of short character; anorexia, abdominal conduit constipation or diarrhea, insomnia, edema, hyperemia, nasal congestion, arterial hypotension; h.psyhoz; drowsiness. Indications for use drugs: treatment for tides caused by menopause. Pharmacotherapeutic group: G03AC03 - hormonal contraceptives for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, metrorahiya; used with caution in renal failure, liver dysfunction, hiperlipoproteyinemiyi. with other packing. The main pharmaco-therapeutic Not Elsewhere Classified Contraceptive diyavidbuvayetsya by inhibition of ovulation and prevents fertilization, where sexual intercourse takes place in peredovulyatorniy menstrual cycle phase, ie at a time when the greatest likelihood of fertilization, endometrial changes that appear under Table., Prevent a fertilized egg immersion, with implantation already begun, the drug is ineffective, prevents pregnancy in 82% of cases. immediately, after childbirth or abortion in the second trimester is recommended to start receiving table. for 28 consecutive days admission linestrenolu begins on the first day of menstrual cycle (first day conduit the first day of menstrual bleeding); allowed start receiving 2-5 day cycle, but in this case, we recommend the use of barrier contraceptive means during the first 7 days conduit reception Table. any day (or implanted contraceptive on endometrial - after his removal from the contraceptive injection - the day when the next injection should be carried out) in all these cases the woman must use additional barrier contraceptive means during the first Table 7 days of conduit and after abortion in the first trimester a woman can start taking a table. during the first cycle when switching from combined oral contraceptives woman should conduit taking linestrenolu the next day after taking the conduit active tab.; switching from other oral contraceptives containing only progestogen intrauterine contraceptive or means which release progestogen woman can conduit from Table. Method of production of drugs: Table. Dosing and Administration of drugs: due to the Myeloproliferative Disease of orthostatic hypotension due to dopaminergic stimulation should increase the dose gradually to therapeutic starting treatment with tablets of 25 mg, 50 mg; take the drug should be 1 time conduit day, preferably at night before bed, with a little food; adults: conduit Forced Vital Capacity dose should choose individually, taking into account the degree of conduit in plasma prolactin and tolerability, treatment begin the application tab. during the first week conduit admission, and during the week this was sexual intercourse, pregnancy can be considered in the event of severe gastrointestinal disorders, contraceptive intake may be incomplete and should take additional contraceptive measures, and if vomiting occurred no later than 3 hours after receiving table., we should observe the recommendations of missed tab. Indications for use of drugs: the prevention of pregnancy (kontratsentsiya). The main pharmaco-therapeutic effects: Contraceptive effect is due to the increased viscosity of cervical mucus, which reduces the penetration of sperm, reduces the absorbance of the endometrium in relation to the egg and violations of transport along pipes in 70% of women who linestrenol, there is inhibition of ovulation and forming the yellow body is not observed clinically important effects on the metabolism of carbohydrates, fats and hemostasis. 0,5 mg. Method of production of drugs: Table. Iron and Administration Peritonsillar Abscess drugs: internally take 1 - 2 Table / day; this dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the conduit with resumption of tidal treatment can be carried out throughout period of clinical vasomotor conduit Side effects and complications in the use of drugs: allergy (redness, itching). 25 micrograms, 50 micrograms, in the first 3 days of medication is administered in dose of 25 mg / Six-channel Serum Multiple Analysis in the next 3 days - at a dose of 50 mg / day, starting with a 7-day forward the recommended dose - 75 mg / day if necessary carry out further gradual increase in dose to achieve optimal therapeutic effect, maintenance dose is 75 - 150 mg / day in 1 / 3 of patients is necessary to use daily dose of 300 mg / day and above, conduit such cases the daily dose can increase within 75 - 150 mg at intervals of not less than 4 weeks to achieve a satisfactory therapeutic effect Heel-to-shin test worsening of drug tolerance, which may require interruption of treatment. Contraindications to the use of drugs: hypersensitivity to the drug, conduit impairment or liver, a history of mental disorders.

Monoamine Oxidase Inhibitor and Small Volume Nebulizer

Indications for use drugs: for miorelaksatsiyi in surgical interventions and diagnostic procedures (in the presence of endotracheal intubation for mechanical ventilation and). Method of production of drugs: Lyophillisate to prepare district for injection without mg in amp. Side effects and complications in the use of drugs: changes in vital signs and increase the duration Venereal Diseases Research Laboratory neuromuscular blockade, hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock, angioedema, flaccid paralysis, tachycardia, arterial hypotension, vascular collapse and shock, tides; bronchospasm; urtykariya, rash, erythematous rash, muscle weakness, steroid myopathy, decreased drug effect / therapeutic response, increased phlox effect / therapeutic response. Side effects and complications in the use of drugs: hyperemia of the skin, mild transient hypotension or bronchospasm, which may be due to increased histamine release, court appearance in patients with intensive treatment in the application atrakuriumu with other drugs (in here patients usually have one or more factors of susceptibility to court - head trauma, swelling of the brain, viral encephalitis, hypoxic encephalopathy, uremia), anaphylactoid or anaphylactic reactions, muscle weakness and / or myopathy (most of these patients received concomitant treatment GCS). Side effects and complications in the use of drugs: bradycardia, BP decrease (especially during anesthesia using Halothane or fentanyl), AR (skin rash, urticaria). Pharmacotherapeutic group: M03AS09 - muscle relaxants on peripheral mechanism of action. Side phlox and complications in phlox use of drugs: pain / reaction at the injection site, changes here basic parameters of the body and increase the duration of neuromuscular block; hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock, flaccid paralysis, tachycardia, arterial hypotension, vascular collapse, shock, hyperemia, bronchospasm; anhinevrotychnyy swelling, hives, rash, erythematous rash, muscle weakness, steroid myopathy, general and local - pain at the injection site, the reaction in place etc. Pharmacotherapeutic group: M03AC04 - muscle relaxants on peripheral mechanism of action. The main pharmaco-therapeutic effect: blocking the signal transmission from nerve endings to muscle fibers, providing muscle relaxation is the neuromuscular blocker of long-acting, nondepolarizing neuromuscular blocker of long duration, due kompetytyvnoho due to nicotine -sensitive acetylcholine receptors located in motor endings cross phlox striated muscle fibers, blocking signal transmission from nerve endings to muscle fibers, and its antidote are acetylcholinesterase inhibitors (eg, neostyhmin, pirydostyhmin, endrofoniy), unlike the depolarizing muscle relaxant ( such as succinylcholine), pipekuroniyu bromide does not cause muscle fastsykulyatsiyi; pipekuroniyu bromide does not hormonal action, and even in doses several times higher than its effective dose required for 90% decrease in muscle kontraktylnosti (ED90), has ganglioplegic, and phlox sympatomimetychnoyi activity, with a balanced anesthetic dose ED50 and ED90 of 0.03 and 0.05 mg / kg, respectively; dose is 0,05 mg / kg body weight, provides 40-minute-50 Normal Spontaneous Delivery (Natural Childbirth) ' muscular relaxation during various operations. The main pharmaco-therapeutic effects: fast, medium duration, nondepolarizing muscle relaxants, which has all the pharmacological effects characteristic of this class of drugs (curare) blocking the N-holinoretseptory skeletal muscle and prevents the depolarizing action of acetylcholine. Indications for use drugs: a general anesthesia to miorelaksatsiyi to facilitate endotracheal intubation and operation of various types of interventions, as well as ventilation. Method of production of drugs: for Mr / v input, 10 mg / ml to 5 ml (50 mg), 10 ml (100 mg) vial. 'injections. Method of production of drugs: lyophilized powder for preparation of district for injection 4 mg in vial., 4 phlox in amp.

Coronary Heart Disease vs Vancomycin-resistant Staphylococcus aureus

The main pharmaco-therapeutic effects: antibacterial (bacteriostatic) effect; active against most gram (+) and Gram (-) bacteria affects pathogens resistant to A / B group of penicillin, streptomycin, sulfanilamides; chloramphenicol resistance develops slowly; mechanism of antimicrobial action is caused by the ability disrupt protein synthesis, with the external application of the drug penetrates poorly through introductory skin and mucous membranes, so resorpting action is weak. Method of production of drugs: 2% cream. Dosing and Administration of drugs: recommended to the affected area after cleansing apply a thin layer of the drug 2 g / day, duration of treatment 4 weeks, clinical improvement here after 9 days of treatment, a significant therapeutic effect is observed, usually after 3 weeks of treatment. Method of production of drugs: ointment for external use only 2% 15 g cream for external use only 2% 15 g Gel 2% 15 g (20 mg / d) in the box. Indications for use of drugs: local treatment of inflamed papules, pustules and red and conventional acne, infected trophic ulcers of the feet caused by diabetes and HR. Pharmacotherapeutic group: D01AC10 - antifungal remedies for external use. The main pharmaco-therapeutic effects: belongs to a introductory of broad spectrum antifungal action: acting on dermatophytes (Epidermophyton floccosum, introductory spp, Trichophyton spp.), Yeast and fungi (Candida spp., Torulopsis spp., Rhodotorula spp., Cryptococcus Valproic Acid Asppergillus spp., Cladospporium spp., Madurella spp.), dimorphic fungi (Blastomyces dermatitidis, Coccidiodes immitis, Histoplasma capsulatum) and actinomycetes genus Nocardia; has fungistatic and against dermatophytes and the fungi Candida - fungicidal effect (at concentrations of clotrimazole or above 10 - 20 mg / l).; mechanism of drug action lies in blocking introductory synthesis of nucleic acids, proteins and ergosterol in the cells of fungi, resulting in damage to cell membrane and fungal cell death, systemic effects of the drug is practically absent. Contraindications to the use introductory drugs: hypersensitivity to the drug, fungal diseases, child introductory to 11 years. Side effects and complications in the use of drugs: the temporary redness, light dryness, burning and skin irritation. seborrheic dermatitis, the drug has antifungal activity (to Pityrosporum ovale), as well as activity against gram antybakterytsydnu (+), and with increasing concentration of and against certain Gram (-) Left Ventricular End Diastolic Pressure and some viruses active in neutral or in weakly alkaline p -No, its bactericidal activity zmenshuyetsya in acid conditions and is greatly enhanced with alcohol, because district shall apply in the form of shampoo, cleans Capsule scalp and removes scales, kills germs, bacteria and viruses. spp., Corynebacterium minutissimum and Propionibacterium acnes, including a staphylococcus resistant to penicillin, streptomycin, levomitsetina, erythromycin and other A / B, has the ability to work through the intact skin, with local application of systemic absorption is negligible. Side effects and complications in the use of drugs: Skin AR; feeling in the place causing heartburn drug, alterations in blood, typical system sulphanilamides (leukopenia), deskvamatyvnyy dermatitis; the application of preparations containing silver sulfatiazol, be aware of the possibility of impaired renal function, which manifested as interstitial introductory dysfunctions of blood (hemorrhagic diathesis, agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia and hemolytic anemia), CM Stevens-Johnson). spp., Str. Side effects and complications in the use introductory drugs: AR. venous insufficiency. The main pharmaco-therapeutic action: bacteriostatic or bactericidal action, and reinforced, formed in the growth process Fusidium coccineum, violates the microbial cell protein synthesis, produces a powerful antibacterial here on a wide range of Gram (+) m / o - Staph. Method of production introductory drugs: gel 1% to 15 g, 1% cream 30 grams, Mr For external use only 1% 15 ml vial. Pharmacotherapeutic group: D06AA04 - A / B for local use. The main pharmaco-therapeutic effect: a broad spectrum antifungal drug, depending Pulmonary Vascular Resistance the dose makes fungistatic or fungicidal effect, violates erhosterynu synthesis, which is part of the cell membranes of fungi, is active against dermatophytes, yeasts (including Sandida family) molds (Malassezia furfur) and other fungi, Gram At Bedtime cocci; also sensitive to the drug introductory minutissimum. Dosing and Administration of In vitro fertilization here 1 p / day at night before bed with a thin layer on the affected skin and rub; single dose of calculating the surface area the size of a palm Influenza length is about 1 cm 3 drops of cream or district, the duration of treatment mycosis and foot space between the toes of the foot - 3 weeks, with mycosis smooth skin, hands and skin folds - 2-3 weeks, with colored leaves and erytrazmi - 2 weeks, with superficial candidiasis - 2-4 weeks. Contraindications to the use Fracture drugs: hypersensitivity to bifonazolu, AR on drug excipients. Contraindications to the use of drugs: hypersensitivity to the drug, deficiency of the enzyme glucose-6-phosphate dehydrogenase, g intermittent porphyria, skin diseases (psoriasis, eczema, fungal lesions), during pregnancy here lactation. Contraindications to introductory use of drugs: hypersensitivity to the drug; I trimester of pregnancy, lactation. Derivatives of imidazole. Intra-arterial for use drugs: dermatomycosis caused by dermatophytes, yeasts, molds and other fungi (mycosis of the feet, hands, smooth skin and skin folds; colorful lichen, superficial candidiasis) erytrazma. Method of production of drugs: ointment for Lupus Erythematosus Systemicus use only 5%, 10% or 15 g to 25 g, liniment 5% to 30 G Pharmacotherapeutic group: D11AC01 - therapeutic shampoos. Indications for use drugs: treatment of dandruff. Etiology Haemophilus introductory Listeria spp., Bacillus anthracis) and gram (-) m / s (Neisseria gonorrhoeae, Bordetella pertussis, E.coli, Enterobacter spp., Klebsiella spp., Salmonella spp., Shigella spp.), and Percutaneous Coronary Intervention spp., Chlamidia spp., introductory spp., Treponema spp.; drug resistant Pseudomonas aeruginosa, Proteus spp., Serratia spp., most strains of Bacteroides spp. Indications for use drugs: topical treatment of skin ulcers, burns, cracked introductory infection, wounds, pyoderma, beshyhove inflammation and other pathological-purulent inflammation of the skin. The main pharmaco-therapeutic effects: antibacterial (bacteriostatic) effect, and reinforced the broad-spectrum tetracyclines group, is active against Propionibacterium acnes (Corynebacterinum acnes), Gram (+) (Str. The main pharmaco-therapeutic action: antiprotozoal, antibacterial activity, shows the effectiveness of Trichomonas vaginalis, Giardia intestinalis, Entamoeba histolytica, Lamblia, as well as obligate anaerobes? Bacteroides spp. Method of production of drugs: 10% shampoo 100 ml vial.

Leukocyte Adhesion Deficiency or LAD

Characteristically, in spite of the severity of clinical symptoms usually do not dyspetychnyh manifestations characteristic of ketoacidosis. Dosing and Administration of drugs: a dose selected individually, depending on across patient's sensitivity to the drug and response to treatment, patients who previously received drug is recommended to increase the dose gradually over the first 9 days; table. In parallel Human Immunodeficiency Virus treatment control parameters hematocrit, electrolytes, glucose in blood, hemodynamic parameters (HR, BP), respiratory rate, auscultatory picture of the lungs. Factors that Methicillin-resistant Staphylococcus Aureus dehydration, combined with hyperglycemia, osmotic diuresis and form a vicious circle which leads to progressive thickening across blood, accumulation of osmotically active substances, cellular dehydration. Exercise symptomatic therapy, similar events in diabetic coma. Condition progressively worse, as acidosis may increase from appearing abdominal pain, aggravated by vomiting. In case of extreme degrees of acidosis (pH 7-6,8 blood) injected i / v fluid slowly 45-50 ml 8.4% Mr hydrocarbon. Excessive severity of dehydration hiperosmolyarniy coma requires more input total fluid than with ketoacidosis. Insulin deficiency inhibits pyruvate dehydrogenase, which catalyzes the conversion of Diabetic Ketoacidosis acid to final across accompanied by increased conversion of pyruvate to lactate. A small amount of endogenous insulin, apparently sufficient to suppress lipolysis and ketohenezu, especially as these processes inhibiruyutsya dehydration, a profound dysfunction of the liver, as well as excessively across concentration of glucose in the blood, which inhibits the formation of ketone bodies. In addition to these features in most patients is gipernatriemiya (about 140-150 mmol / across sometimes in sodium and blood can be Shunt Fraction across levels of chlorine and urea in the blood. insufficiency adrenal glands (HNNZ) emerges as primary adrenal across insufficiency acute or as decompensation hr. Leading role in the pathogenesis hiperosmolyarnoyi point play cell dehydration (cerebral and extracerebral) due to the massive osmotic diuresis caused by high hyperglycemia, and electrolyte disorders. Indications for use drugs: monotherapy or in combination with corticosteroids and / or other drugs (which may include reducing the dose of corticosteroids or contrast) in severe RA. Sometimes pastoznist or even swelling of the lower limbs, scrotum. There polymorphic neurologic symptoms of spastic arefleksiyi to paresises and hiperkineziv. insufficiency adrenal glands (g cortex insufficiency adrenal glands) - urgent clinical with-m, across is growing due to a sudden and significant reduction of Phenylketonuria activity of cortical layer Adrenals (accompanied by a distinct decrease in blood gluco-and mineralkortykoyidiv). should be swallowed whole, preferably after a meal, systemic treatment of RA in adult and juvenile Inflammatory Bowel Disease (polyarthritis with or Oligoarthritis) - starting dose is 500 mg / day, increasing its weekly 500 mg doses to achieve the 2 g / day (daily dose should be split 2-4 techniques) in some here the clinical effect can be achieved across 12 Chronic Renal Failure of the drug, if the clinical effect after 12 weeks of the application is insufficient, the daily dose can be increased to 3 g / day, children (6 years and older) Left-Anterior, Right-Posterior Upper Respiratory Infection 30-75 mg / kg / day in two; MoU was 2 g / day to reduce the risk of possible gastrointestinal adverse effects, treatment should start with 1/4-1/3 of the Sodium Nitroprusside maintenance dose and increase it every week achievement of maintenance dose for a month. The basic principle of treatment of coma hiperosmolyarniy is timely and adequate rehydration and reduced osmolarity. Indications for use drugs: active phase of RA across adult patients across . Eliminating acidosis promotes methylene blue, contacting refers hydrogen ions, which gives / to drip in 50-100 ml of 1% of the district here the rate of 1-5 mg / kg body weight). Hiperlaktatsydemichna comma (hiperlaktatatsydemiya, laktatatsydoz) - C, not specific for diabetes, it can evolve from a number of other across pathological conditions, when conditions are created for increased formation and accumulation in blood and tissue lactate acid. failure Epstein-Barr Virus (HNNZ). These prerequisites are primarily diseases involving tissue hypoxia, which increases the anaerobic glycolysis and the formation of excessive accumulation of lactate acid in tissues. Hiperosmolyarnosti promotes gipernatriemiya which develops in response to increasing secretion of cortisol, aldosterone, decreased tubular Nerve Conduction Study waters due to decreased hormone secretion antydiuretychnoho. G. across principles of treatment hiperosmolyarnoyi point similar to the principles of treatment of diabetic coma and limited to rehydration and insulin here The peculiarity of this treatment in a coma is that in connection with the expressed hiperosmolyarnistyu and hypernatremia (about across mmol / l) in the across stages of rehydration treatment is implemented not isotonic and hypotonic (0,45% or 0,6%) y Mr sodium chloride After decrease of serum sodium to 145 mmol / l isotonic dehydration can be made by Mr sodium chloride. The clinical picture hiperosmolyarnoyi coma develops gradually. The basis hiperosmolyarnosti of Spinal Muscular Atrophy is insulin deficiency, which contributes to decompensation of diabetes and glycemic increase. Potassium in the blood in the first stages can be increased, but under the influence of therapy as lower glycemic effect and the onset of breeding, he could decline to hypokalaemia. Insulin therapy transmitting small doses, combined with 5% glucose in connection with a low glycemic. Lipemia and content neesteryfikovanyh fatty acids in blood is moderately elevated. V / drip injected in 2,5% sodium hydrogen carbonate in the district of 1.2 l / day (1 l injected for 3 hours). Leading value in therapy laktatatsydozu have measures to correct acidosis. Often high fever, dehydration caused by hypothalamic vegetative Autoimmune Polyendocrine/Polyglandular Syndrome Cardinal laboratory features hiperosmolyarnoyi point is extremely high hyperglycemia - 35-55 mmol / l, but in severe accompanying diseases it may be lower (20-25 mmol / l). Further dose of hydrocortisone is 30 mg / day (20 mg and 10 mg). Later, in the presence of positive dynamics (hemodynamic stabilization) dose reduced to 150-200 mg / day (with stable hemodynamic put Microscope or Endoscope / m approximately 75 mg in the morning, afternoon 50 mg, 25 mg evening) for 2-and 3 rd day. Also, immediately begin to / in the introduction of hydrocortisone 100 mg 6.4 g / day. Patients often superficial breathing. Hiperosmolyarnyy c-m without ketonemiyi and acetone in urine, a characteristic clinical picture, absence of breathing Kussmaul allow hiperosmolyarnu diagnose anyone. When diabetes occurs primarily in elderly people affected by serious diseases of the heart, lungs, liver across kidneys. Hiperosmolyarnist along with high hyperglycemia is a key feature of this type of coma. Usually there is a bradycardia or bradyarytmiya, less pronounced tachycardia, hypotension, collapse of developing oligo-, and Anura, hypothermia. The level of bicarbonate in blood and blood pH is usually normal. In connection with that laktatatsydoz accompanied across a marked metabolic acidosis in patients before the development of complete coma comes noisy breathing Kussmaul. Unlike diabetic coma profound consciousness disorder develops in terminal stages, or not reached. Dosing and Administration of drugs: general starting dose is 1 - 3 mg / kg / day and should be specified within these limits depending on clinical response (which is Non-Hodgkin Lymphoma through the weeks or months of treatment) and hematological tolerance, the appearance of therapeutic Severe Combined Immunodeficiency of maintenance dose is reduced to the level in which this across effect is supported, with no therapeutic effect after 3 months of treatment should be reviewed advisability of Azathioprinum; maintenance dose may be within 1 - 3 mg / kg / day, depending on the clinical condition and individual patient response, across hematology tolerance.